Search research articles
Contact Us
Filters
Showing results (1-10 of 155) with videos related to
Page
of 16
Sort By:
Anais Da Academia Brasileira De Ciencias
|
August 1, 2019
What is hidden in the biodiversity? The role of natural products and medicinal chemistry in the drug discovery process
Eliezer J Barreiro
Current Medicinal Chemistry
|
February 14, 2006
Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs
Carlos A M Fraga, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry
|
February 23, 2018
Recent Advances in Development of Polyphenols as Anticancer Agents
Sreekanth Thota, Daniel Alencar Rodrigues, Eliezer J Barreiro
RSC Medicinal Chemistry
|
May 28, 2021
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M<sup>PRO</sup>) through <i>in silico</i> screening supported by molecular docking and a fragment-based pharmacophore model
Lucas S Franco, Rodolfo C Maia, Eliezer J Barreiro
Organic & Biomolecular Chemistry
|
January 23, 2016
The total synthesis of calcium atorvastatin
Luiz C Dias, Adriano S Vieira, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry
|
November 30, 2007
Privileged structures: a useful concept for the rational design of new lead drug candidates
Carolina D Duarte, Eliezer J Barreiro, Carlos A M Fraga
Current Topics in Medicinal Chemistry
|
July 2, 2019
Chemical Intuition in Drug Design and Discovery
Júlia G B Pedreira, Lucas S Franco, Eliezer J Barreiro
Journal of Medicinal Chemistry
|
February 16, 2018
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota, Daniel A Rodrigues, Debbie C Crans, et al.
Mini Reviews in Medicinal Chemistry
|
June 13, 2009
From nature to drug discovery: the indole scaffold as a 'privileged structure'
Fernando Rodrigues de Sá Alves, Eliezer J Barreiro, Carlos Alberto Manssour Fraga
The Journal of Pharmacy and Pharmacology
|
July 20, 2017
The antithrombotic and haemostatic effects of LASSBio-752: a synthetic, orally active compound in an arterial and venous thrombosis model in rats
Flávia S Frattani, Lidia M Lima, Eliezer J Barreiro, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 155) with videos related to
Sort By:
Page
of 16
Anais Da Academia Brasileira De Ciencias
|
August 1, 2019
What is hidden in the biodiversity? The role of natural products and medicinal chemistry in the drug discovery process
Eliezer J Barreiro
Current Medicinal Chemistry
|
February 14, 2006
Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs
Carlos A M Fraga, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry
|
February 23, 2018
Recent Advances in Development of Polyphenols as Anticancer Agents
Sreekanth Thota, Daniel Alencar Rodrigues, Eliezer J Barreiro
RSC Medicinal Chemistry
|
May 28, 2021
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M<sup>PRO</sup>) through <i>in silico</i> screening supported by molecular docking and a fragment-based pharmacophore model
Lucas S Franco, Rodolfo C Maia, Eliezer J Barreiro
Organic & Biomolecular Chemistry
|
January 23, 2016
The total synthesis of calcium atorvastatin
Luiz C Dias, Adriano S Vieira, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry
|
November 30, 2007
Privileged structures: a useful concept for the rational design of new lead drug candidates
Carolina D Duarte, Eliezer J Barreiro, Carlos A M Fraga
Current Topics in Medicinal Chemistry
|
July 2, 2019
Chemical Intuition in Drug Design and Discovery
Júlia G B Pedreira, Lucas S Franco, Eliezer J Barreiro
Journal of Medicinal Chemistry
|
February 16, 2018
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota, Daniel A Rodrigues, Debbie C Crans, et al.
Mini Reviews in Medicinal Chemistry
|
June 13, 2009
From nature to drug discovery: the indole scaffold as a 'privileged structure'
Fernando Rodrigues de Sá Alves, Eliezer J Barreiro, Carlos Alberto Manssour Fraga
The Journal of Pharmacy and Pharmacology
|
July 20, 2017
The antithrombotic and haemostatic effects of LASSBio-752: a synthetic, orally active compound in an arterial and venous thrombosis model in rats
Flávia S Frattani, Lidia M Lima, Eliezer J Barreiro, et al.
Page
of 16